Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
28.20
Dollar change
-0.11
Percentage change
-0.39
%
IndexRUT P/E- EPS (ttm)-8.66 Insider Own3.85% Shs Outstand73.10M Perf Week8.71%
Market Cap2.13B Forward P/E- EPS next Y-6.23 Insider Trans-1.70% Shs Float72.56M Perf Month0.14%
Income-641.70M PEG- EPS next Q0.49 Inst Own112.20% Short Float14.31% Perf Quarter31.28%
Sales798.18M P/S2.67 EPS this Y24.45% Inst Trans1.90% Short Ratio9.50 Perf Half Y-29.54%
Book/sh-8.89 P/B- EPS next Y-5.83% ROA-45.25% Short Interest10.38M Perf Year-33.16%
Cash/sh3.91 P/C7.22 EPS next 5Y-9.51% ROE- 52W Range17.53 - 59.84 Perf YTD2.32%
Dividend Est.- P/FCF- EPS past 5Y-31.05% ROI-3336.98% 52W High-52.87% Beta0.67
Dividend TTM- Quick Ratio1.03 Sales past 5Y27.80% Gross Margin71.37% 52W Low60.87% ATR (14)1.31
Dividend Ex-Date- Current Ratio1.10 EPS Y/Y TTM-16.06% Oper. Margin-64.29% RSI (14)60.44 Volatility5.05% 4.72%
Employees1410 Debt/Eq- Sales Y/Y TTM14.58% Profit Margin-80.40% Recom2.93 Target Price27.83
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-15.63% Payout- Rel Volume0.71 Prev Close28.31
Sales Surprise-6.50% EPS Surprise-65.26% Sales Q/Q-9.46% EarningsFeb 29 AMC Avg Volume1.09M Price28.20
SMA208.52% SMA503.81% SMA200-12.64% Trades Volume779,991 Change-0.39%
Date Action Analyst Rating Change Price Target Change
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $28
Dec-08-23Initiated Wells Fargo Overweight $37
Oct-30-23Upgrade Oppenheimer Perform → Outperform $165
Oct-27-23Downgrade Citigroup Neutral → Sell $29 → $17
Oct-06-23Downgrade Truist Buy → Hold $45 → $25
Sep-18-23Downgrade Citigroup Buy → Neutral $55 → $28
Sep-15-23Downgrade Raymond James Outperform → Underperform
Mar-17-23Initiated SVB Securities Market Perform $48
Dec-14-22Initiated Goldman Sell $35
Sep-12-22Initiated Jefferies Buy $62
Feb-27-24 05:20PM
Feb-26-24 09:16AM
Feb-22-24 04:30PM
Feb-15-24 08:00AM
Feb-13-24 10:00AM
01:45AM Loading…
Feb-11-24 01:45AM
Jan-26-24 04:06PM
11:45AM
10:18AM
Jan-25-24 04:51PM
04:20PM
04:05PM
Jan-24-24 07:02PM
Jan-12-24 01:02AM
Jan-08-24 09:26AM
08:00AM Loading…
Jan-03-24 08:00AM
Dec-20-23 09:41AM
Dec-15-23 05:01PM
Dec-14-23 04:30PM
Dec-05-23 04:15PM
Nov-14-23 03:58PM
Nov-03-23 04:30PM
Oct-30-23 09:03AM
Oct-27-23 11:22AM
10:01AM
08:33AM
07:15AM
02:38AM
Oct-26-23 07:30PM
06:10PM
05:30PM Loading…
05:30PM
04:25PM
04:05PM
Oct-24-23 10:00AM
Oct-19-23 07:02PM
10:01AM
08:00AM
Oct-16-23 04:30PM
Oct-11-23 08:07AM
Oct-06-23 09:42AM
Sep-29-23 11:18AM
Sep-28-23 05:15PM
04:42PM
04:30PM
Sep-25-23 03:18AM
Sep-20-23 04:00AM
Sep-19-23 06:46AM
Sep-15-23 04:04PM
09:28AM
06:00AM
Sep-12-23 08:00AM
Sep-07-23 07:33PM
08:00AM
08:00AM
Aug-30-23 08:00AM
Aug-28-23 08:00AM
Aug-25-23 01:38PM
Aug-04-23 01:24PM
Aug-03-23 09:30PM
05:25PM
04:14PM
04:01PM
Jul-21-23 09:30AM
Jul-20-23 08:00AM
Jul-19-23 04:30PM
Jul-18-23 04:30PM
Jul-17-23 04:30PM
Jul-11-23 12:00PM
Jun-30-23 10:18AM
Jun-29-23 04:30PM
09:18AM
Jun-28-23 07:41AM
Jun-21-23 04:24PM
07:31AM
07:12AM
07:00AM
Jun-15-23 04:30PM
Jun-02-23 08:00AM
May-31-23 06:05AM
May-25-23 10:32AM
May-24-23 04:06PM
12:48PM
12:33PM
May-23-23 05:36PM
04:07PM
04:05PM
May-18-23 12:59PM
May-17-23 04:02PM
12:28PM
07:00AM
Apr-29-23 08:14AM
Apr-28-23 11:31AM
08:00AM
Apr-27-23 05:35PM
04:01PM
12:00PM
Apr-21-23 10:00AM
Apr-20-23 10:02AM
Apr-13-23 08:00AM
Apr-05-23 06:08AM
PTC Therapeutics, Inc. is a biopharmaceutical company. It engages in discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boulding Mark ElliottEXEC. VP AND CLOJan 30Sale27.2579421,63771,189Feb 01 04:17 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 30Sale27.2561816,84161,202Feb 01 04:18 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 30Sale27.253669,97444,181Feb 01 04:16 PM
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICERJan 30Sale27.253188,66635,528Feb 01 04:15 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 30Sale27.25287633,706Feb 01 04:18 PM
Jacobson Allan StevenDirectorJan 22Option Exercise27.0510,000270,50022,348Jan 24 04:30 PM
Jacobson Allan StevenDirectorJan 22Sale27.3810,000273,80412,348Jan 24 04:30 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 09Sale29.015,443157,928160,475Jan 10 04:08 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 09Sale29.012,06559,91644,547Jan 10 04:09 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 09Sale29.011,93856,23171,983Jan 10 04:04 PM
Utter Christine MarieSVP, FINANCE & CAOJan 09Sale29.011,65347,96135,846Jan 10 04:11 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 09Sale29.011,52144,13261,820Jan 10 04:03 PM
Golden Lee ScottCHIEF MEDICAL OFFICERJan 09Sale29.011,22535,54337,914Jan 10 04:06 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 09Sale29.011002,9013,734Jan 10 04:03 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 08Sale28.642,23764,068165,918Jan 10 04:08 PM
Pauwels EricCHIEF BUSINESS OFFICERJan 08Sale28.641,56944,93746,612Jan 10 04:09 PM
Boulding Mark ElliottEXEC. VP AND CLOJan 08Sale28.641,45741,72973,921Jan 10 04:04 PM
SCHMERTZLER MICHAELDirectorJan 08Sale27.811,50041,715115,266Jan 10 04:10 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 08Sale28.641,23635,39963,341Jan 10 04:03 PM
Utter Christine MarieSVP, FINANCE & CAOJan 08Sale28.641,18834,02537,499Jan 10 04:11 PM
Golden Lee ScottCHIEF MEDICAL OFFICERJan 08Sale28.6477522,19639,139Jan 10 04:06 PM
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICERJan 08Sale28.64531,5183,834Jan 10 04:03 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERJan 05Sale27.1510,107274,393168,155Jan 09 04:29 PM
Gravier PierreCHIEF FINANCIAL OFFICERDec 12Buy25.817,700198,73633,700Dec 14 04:38 PM
Young AlethiaDirectorSep 06Option Exercise27.8511,666324,89816,067Sep 08 04:02 PM
Young AlethiaDirectorSep 06Sale39.8611,666464,9729,067Sep 08 04:02 PM
SCHMERTZLER MICHAELDirectorJun 07Sale44.861,00044,860116,766Jun 09 04:03 PM
Reeve EmmaDirectorMay 23Option Exercise33.382,65288,5208,602May 24 04:12 PM
Reeve EmmaDirectorMay 23Sale59.532,652157,8857,200May 24 04:12 PM
Reeve EmmaDirectorMay 22Option Exercise33.377,116237,48411,148May 24 04:12 PM
Reeve EmmaDirectorMay 22Sale59.537,116423,6307,200May 24 04:12 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 22Sale59.012,013118,79147,553May 23 04:05 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 19Sale58.966,403377,49149,566May 23 04:05 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 18Sale58.7178846,26755,969May 19 04:04 PM
Pauwels EricCHIEF BUSINESS OFFICERMay 17Sale58.508,048470,82256,757May 19 04:04 PM
Jacobson Allan StevenDirectorMay 11Option Exercise10.8523,000249,55035,348May 12 04:08 PM
Jacobson Allan StevenDirectorMay 11Sale55.0823,0001,266,93012,348May 12 04:08 PM
Utter Christine MarieSVP, FINANCE & CAOApr 21Option Exercise33.024,692154,93042,380Apr 25 04:09 PM
Utter Christine MarieSVP, FINANCE & CAOApr 21Sale55.064,692258,32638,059Apr 25 04:09 PM
Reeve EmmaDirectorApr 21Sale55.054,328238,2587,200Apr 25 04:08 PM
Klein Matthew B.CHIEF EXECUTIVE OFFICERApr 18Sale52.041,21163,025102,645Apr 20 04:05 PM
Pauwels EricCHIEF BUSINESS OFFICERApr 18Sale52.0473238,09664,805Apr 20 04:07 PM
Boulding Mark ElliottEXEC. VP AND CLOApr 17Option Exercise30.8661,9231,910,944134,009Apr 19 04:09 PM
SOUTHWELL DAVID PDirectorApr 17Option Exercise18.0111,429205,83621,929Apr 19 04:11 PM
Boulding Mark ElliottEXEC. VP AND CLOApr 17Sale51.4261,9233,183,83075,378Apr 19 04:09 PM
SOUTHWELL DAVID PDirectorApr 17Sale51.0311,429583,18710,500Apr 19 04:11 PM
SOUTHWELL DAVID PDirectorMar 31Option Exercise18.012,57146,30413,071Apr 04 04:07 PM
SOUTHWELL DAVID PDirectorMar 31Sale50.052,571128,67210,500Apr 04 04:07 PM
Utter Christine MarieSVP, FINANCE & CAOMar 29Option Exercise40.454,688189,63042,747Mar 31 04:21 PM
Utter Christine MarieSVP, FINANCE & CAOMar 29Sale47.794,688224,04438,059Mar 31 04:21 PM
Utter Christine MarieSVP, FINANCE & CAOMar 27Option Exercise33.0226,658880,24754,988Mar 29 04:22 PM
SOUTHWELL DAVID PDirectorMar 27Option Exercise27.0510,000270,50020,500Mar 29 04:20 PM
Utter Christine MarieSVP, FINANCE & CAOMar 27Sale45.0926,6581,202,10638,059Mar 29 04:22 PM
SOUTHWELL DAVID PDirectorMar 27Sale45.1010,000450,95610,500Mar 29 04:20 PM
Hill Emily LuisaCHIEF FINANCIAL OFFICERMar 27Sale45.007,363331,33538,925Mar 29 04:19 PM